Search research articles
Contact Us
Filters
Showing results (51-60 of 289) with videos related to
Page
of 29
Sort By:
Neurogenetics
|
September 25, 2008
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
John S K Kauwe, Jun Wang, Kevin Mayo, et al.
Plos One
|
October 3, 2013
Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration
Robyn A Honea, Carlos Cruchaga, Rodrigo D Perea, et al.
Biological Psychiatry
|
November 7, 2009
Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease
Anthony L Hinrichs, Mark A Mintun, Denise Head, et al.
Annals of Neurology
|
February 27, 2010
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
John C Morris, Catherine M Roe, Chengjie Xiong, et al.
Scientific Reports
|
November 8, 2019
Empirical design of a variant quality control pipeline for whole genome sequencing data using replicate discordance
Robert P Adelson, Alan E Renton, Wentian Li, et al.
Neuron
|
March 17, 2022
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias
Yuka A Martens, Na Zhao, Chia-Chen Liu, et al.
BMC Genomics
|
July 1, 2016
Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid
Lyndsay A Staley, Mark T W Ebbert, Sheradyn Parker, et al.
BMC Genetics
|
September 2, 2008
In search of causal variants: refining disease association signals using cross-population contrasts
Nancy L Saccone, Scott F Saccone, Alison M Goate, et al.
Neurobiology of Disease
|
February 23, 2020
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
Simon Hsu, Anna A Pimenova, Kimberly Hayes, et al.
Annals of Neurology
|
December 14, 2011
Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data
Andrei G Vlassenko, Mark A Mintun, Chengjie Xiong, et al.
Page
of 29
Search research articles
Search
Showing results (51-60 of 289) with videos related to
Sort By:
Page
of 29
Neurogenetics
|
September 25, 2008
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
John S K Kauwe, Jun Wang, Kevin Mayo, et al.
Plos One
|
October 3, 2013
Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration
Robyn A Honea, Carlos Cruchaga, Rodrigo D Perea, et al.
Biological Psychiatry
|
November 7, 2009
Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease
Anthony L Hinrichs, Mark A Mintun, Denise Head, et al.
Annals of Neurology
|
February 27, 2010
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
John C Morris, Catherine M Roe, Chengjie Xiong, et al.
Scientific Reports
|
November 8, 2019
Empirical design of a variant quality control pipeline for whole genome sequencing data using replicate discordance
Robert P Adelson, Alan E Renton, Wentian Li, et al.
Neuron
|
March 17, 2022
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias
Yuka A Martens, Na Zhao, Chia-Chen Liu, et al.
BMC Genomics
|
July 1, 2016
Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid
Lyndsay A Staley, Mark T W Ebbert, Sheradyn Parker, et al.
BMC Genetics
|
September 2, 2008
In search of causal variants: refining disease association signals using cross-population contrasts
Nancy L Saccone, Scott F Saccone, Alison M Goate, et al.
Neurobiology of Disease
|
February 23, 2020
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
Simon Hsu, Anna A Pimenova, Kimberly Hayes, et al.
Annals of Neurology
|
December 14, 2011
Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data
Andrei G Vlassenko, Mark A Mintun, Chengjie Xiong, et al.
Page
of 29